Prediction & Mechanisms of Recovery Following IEDS

April 12, 2024 updated by: Jon Marsden, University of Plymouth

A Prospective and Retrospective Observational Study of Symptoms and Mechanisms of Recovery in People With Inner Ear Decompression Sickness (IEDS)

Inner Ear Decompression sickness (IEDS) accounts for 20% of all types of decompression sickness (the bends) in divers. The condition commonly affects the peripheral vestibular system (inner ear). IEDS results in acute symptoms of dizzyness (vertigo) and imbalance. Even with the recommended treatment of hyperbaric oxygen therapy some people do not recovery fully. However, even in the presence of a permanent vestibular deficit many people can show a behavioural recovery where symptoms improve over time. Recovery can be aided by vestibular rehabilitation (VR) which is now routine for acute IEDS but was not provided before 2021, and is not widespread across the UK (United Kingdom) or world, meaning people may have a suboptimal recovery.

This project will investigate if and how people recover after an acute episode of IEDS and whether people who had IEDS in the past show changes in the central (brain) processing of vestibular function and in symptoms of dizziness, balance and posture.

This project has two main parts. Part one is a prospective observational study where people with an acute onset of IEDS are serially monitored while they are receiving hyperbaric treatment and VR over 10-14 days. Part two is a retrospective observational study where who have had IEDS in the past 15 years are re-assessed in a one-off session. The tests in both parts involve clinical tests and specialist eye movement recordings that assess vestibular function. We will also determine the site of any vestibular pathology by using selective stimulation of the vestibular end organ or nerve and assess whether there are any changes in how the structure and function of central vestibular pathways in the brain. In people with chronic IEDS with vestibular symptoms we will offer participants a course of VR over 12 weeks and assess whether this is associated with any improvement in symptoms.

Study Overview

Status

Not yet recruiting

Detailed Description

Decompression sickness after diving can occur following a rapid ascent. Here, nitrogen, absorbed by the body when breathing compressed air at depth, comes out of solution and forms microbubbles in the blood. Inner ear decompression sickness (IEDS) accounts for approximately 20% of all cases of decompression sickness. The vestibular system is involved in ~85% cases of IEDS resulting in symptoms of vertigo, nausea, vomiting and unsteadiness with hearing loss and tinnitus.

The strong association of IEDS with a patent foramen ovale (50-73% of cases) suggests that a shunted venous gas embolism causes damage to the vestibular apparatus, which is particularly vulnerable due to its low perfusion and thus slow inert gas washout, compared to the cochlea and other brain structures. It is hypothesised that the nitrogen bubbles within the blood vessels trigger an inflammatory reaction in the endothelium with a coagulation cascade that leads to hypoxic injury and/or that there is direct damage to the membranous labyrinth. Animal models of rapid decompression suggest that it can cause a haemorrhage within the labyrinth with ectopic bone growth and fibrosis occurring over the next month. Advances in the imaging of the inner ear using a gadolinium-based contrast agent (GBCA) allow us to explore structural changes in human divers. Imaging can also help to differentially diagnose another potential cause of diving induced dizziness, superior structural dehiscence syndrome

Decompression sickness and the subsequent inflammatory response requires emergency treatment using with hyperbaric oxygen. The effects of hyperbaric therapy and rehabilitation are not uniform across participants, factors affecting recovery include a high clinical score on admission and a delay in hyperbaric recompression of over 6 hours. Complete recovery is seen in only about 30% of cases. Previous studies have highlighted that people who do not fully recover can have a variety of symptoms that can affect work, hobbies and well-being. These include feelings of instability in some situations (working at a height and with movement) and imbalance in the dark or when changing position.

In people with permanent vestibular pathology, symptoms can still improve due to central adaptive processes within the brain termed vestibular compensation. Clinical studies in other types of peripheral vestibular dysfunction show that it is possible to facilitate the compensation process and symptom recovery through vestibular rehabilitation. Early access to vestibular rehabilitation is now routine practice at the Diving Diseases Research Centre (DDRC) where patients are treated in the South-West UK. This is coupled to diagnosis and monitoring of vestibular function using objective laboratory tests (rotary testing) and clinical tests.

Animal studies highlight the mechanisms underlying vestibular compensation following a peripheral nerve lesion. These focus on changes in the interconnections between brainstem nuclei (e.g. vestibular nuclei) and the cerebellum and re-weighting of the relative importance of multi-sensory sensory inputs. Human studies in chronic peripheral dysfunction also suggest there are recovery-related changes in cortical areas that normally process vestibular information over time. Functional changes in the acute stages include an increase in contralesional activity in the parietoinsular vestibular cortex as well as interlinked subcortical areas (posterolateral thalamus, anterior cingulate gyrus, pontomesencephalic brainstem, hippocampus) with a decrease in activity was seen in the visual, somatosensory and auditory cortices. Structural changes over the first 3 months post lesion include increases in grey matter volume in the vestibular cortex, bilateral hippocampus, visual cortices and the cerebellum.

Within the DDRC vestibular rehabilitation has only been routinely undertaken for people diagnosed with IEDS since 2021. As complete recovery is seen in only about 30% of cases [9]; this suggests that there may be a cohort of patients with residual vestibular symptoms. In surveys of the aural and vestibular effects of diving, including those conducted by the DDRC, 79% (of 790 respondents) have reported aural related problems after learning to dive. Of those with reported problems 46% did not seek any medical advice and 39% specifically reported dizziness / vertigo. In total this suggests that at least 14% of all divers may have undiagnosed vestibular problems that could benefit from vestibular rehabilitation. A case review highlights that since 1999 there have been 79 cases of clinically diagnosed IEDS at the DDRC. Therefore, there is a need to assess and provide rehabilitation support to people with past IEDS and potentially in the future a larger cohort of divers with previously undiagnosed symptoms.

This study plans to:

undertake a prospective observational study where people with acute onset IEDS are followed up. This will include the current battery of clinical and laboratory (rotary) tests but also additional optional clinical and physiological testing (Vestibular Evoked Myogenic Potentials VEMPs), imaging (Diffusor Tensor Imaging DTI and functional Magnetic Resonance Imaging f MRI) and semis-structured interviews in the acute (1-14 days) and chronic (3 months and 12 months) stage.

We will also:

undertake a retrospective cross-sectional study of people who have previously been managed for IEDS by the DDRC. Here we will undertake the same battery of tests as for the prospective study which includes measures of potential risk factors and patient reported outcome measures. We will also take this opportunity to explore people's symptoms post IEDS and their views on future rehabilitation trials. In those with remaining vestibular symptoms and signs we will provide advice on vestibular rehabilitation by qualified personnel with follow up as required. We will compare our data to a cohort of healthy controls of a similar age and gender distribution.

Study Type

Observational

Enrollment (Estimated)

41

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Population: Divers

Exposure: Dive resulting in IEDS symptoms

Description

Prospective Study

Inclusion

Divers admitted with suspected IEDS

Exclusion

Medically unstable

Unstable orthopaedic deficits

Retrospective study

Inclusion

Divers diagnosed with IEDS at DDRC within past 10 years

Exclusion

We will include all co-morbidities as these could affect prognosis and recovery following IEDS.

Healthy control comparator group :

Normative data will be gathered on an age matched group. There will be at least 10 participants for each decade (<30yrs ,30-40yrs, 40-50 yrs,50-60yrs,60-70 yr.)

Inclusion criteria: Adults over 18 years

Exclusion criteria: Neurological, sensory or orthopaedic conditions that could affect balance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Prospective Cohort
Divers admitted with suspected IEDS
Retrospective Cohort
Divers diagnosed with Inner ear decompression sickness (IEDS) at Deep Diving Research Centre within past 10 years

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Side of peripheral vestibular damage: Prospective cohort
Time Frame: T0=baseline within 24 hrs of IEDS in the prospective cohort
Side (left or right) of vestibular dysfunction as determine by video head impulse test (v HIT) testing
T0=baseline within 24 hrs of IEDS in the prospective cohort
Site of peripheral vestibular damage: Prospective cohort
Time Frame: T0=baseline within 24 hrs of IEDS in the prospective cohort
Site of dysfunction: semi-circular canals affected as determine by v HIT testing. One or a combination of Horizontal, anterior or posterior canals.
T0=baseline within 24 hrs of IEDS in the prospective cohort
Extent of peripheral vestibular damage: Prospective cohort
Time Frame: T0=baseline within 24 hrs of IEDS in the prospective cohort
VOR gain (unit less) as measured by v HIT at T0 (Range 0-1 higher values are better outcome)
T0=baseline within 24 hrs of IEDS in the prospective cohort
Side of peripheral vestibular damage: Retrospective cohort
Time Frame: 1 time point: 0-10 years post injury
Side (left or right) of vestibular dysfunction as determine by video head impulse test (v HIT) testing
1 time point: 0-10 years post injury
Site of peripheral vestibular damage:Retrospective cohort
Time Frame: 1 time point: 0-10 years post injury
Site of dysfunction: semi-circular canals affected as determine by v HIT testing.One or a combination of Horizontal, anterior or posterior canals.
1 time point: 0-10 years post injury
Extent of peripheral vestibular damage:Retrospective cohort
Time Frame: 1 time point: 0-10 years post injury
VOR gain (unit less) at T0 (Range 0-1 higher values are better outcome)
1 time point: 0-10 years post injury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VOR gain v HIT: Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0) in VOR gain assessed through V HIT test . Gain is unit less and range from 0-1 where higher values indicate a better clinical outcome.
7-10 days , 3 months and 12 months post injury
VOR gain: Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0) in VOR gain assessed through sinusoidal rotation in the dark . Gain is unit less and range from 0-1 where higher values indicate a better clinical outcome.
7-10 days , 3 months and 12 months post injury
VOR Time constant:Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0)in VOR time constant in response to a step rotation (initial 140°/s acceleration/deceleration and a 60°/s fixed-chair velocity) stimulus . Time constant (seconds) where a higher time constant is clinically better. Range 0-40s.
7-10 days , 3 months and 12 months post injury
Patient reported outcome measure: Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0) in PROM (patient reported outcome measure) vertigo severity scale.15 questions rated 0-4. Score range =0-60 where lower scores indicate a better clinical outcome
7-10 days , 3 months and 12 months post injury
Clinical measure of walking: Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0) in Dynamic Gait Assessment (DGA). Eight tasks scored 0-3. Total range = 0-24 with a higher score indicating better walking ability.
7-10 days , 3 months and 12 months post injury
Clinical measure of balance: Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0) in Clinical measures of balance sharpened Romberg (tandem stance). The length of time a person is able to stand in the eyes open, tandem stance position is recorded up to a maximum of 30 seconds.
7-10 days , 3 months and 12 months post injury
Posturography: Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0) in Postural sway quotient. Postural sway (mm/s) is measured via force plates. The ratio of the sway with eyes open and eyes closed is calculated (unitless ratio).
7-10 days , 3 months and 12 months post injury
Perception of verticality: Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0) in Rod and Disk test: The ability to orientate a line to vertical is assessed with / without visual distractors. The error from vertical is recorded in degrees. Outcomes range from 0-180 degrees where lower numbers indicate better verical perception.
7-10 days , 3 months and 12 months post injury
Functional MRI response to an optokinetic stimulus: Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0) in Regions of interest will also assess changes in activation with an optokinetic stimulus compared to rest in cortical and subcortical sites that process vestibular information namely the insulo-parietal cortex and hippocampus and sites that process other sensory information namely the visual cortex and somatosensory cortex
7-10 days , 3 months and 12 months post injury
Vestibular Evoked myogenic Potentials latency: Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0) in Galvanic and Auditory Vestibular Evoked myogenic Potentials (VEMPs) will be assessed and the latency of evoked responses measured in milliseconds.
7-10 days , 3 months and 12 months post injury
Vestibular Evoked myogenic Potentials amplitude: Prospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
Change from baseline (T0) in Galvanic and Auditory Vestibular Evoked myogenic Potentials (VEMPs) will be assessed and the amplitude of evoked responses measured in millivolts.
7-10 days , 3 months and 12 months post injury
VOR gain: Retrospective Study
Time Frame: 7-10 days , 3 months and 12 months post injury
VOR gain assessed through sinusoidal rotation in the dark . Gain is unit less and range from 0-1 where higher values indicate a better clinical outcome.
7-10 days , 3 months and 12 months post injury
VOR Time constant: Retrospective Study
Time Frame: 1 time point: 0-10 years post injury
VOR time constant in response to a step rotation (initial 140°/s acceleration/deceleration and a 60°/s fixed-chair velocity) stimulus . Time constant (seconds) where a higher time constant is clinically better. Range 0-40s.
1 time point: 0-10 years post injury
Patient reported outcome measure: Retrospective Study
Time Frame: 1 time point: 0-10 years post injury
PROM (patient reported outcome measure) vertigo severity scale.15 questions rated 0-4. Score range =0-60 where lower scores indicate a better clinical outcome
1 time point: 0-10 years post injury
Clinical measure of walking: Retrospective Study
Time Frame: 1 time point: 0-10 years post injury
Dynamic Gait Assessment (DGA). Eight tasks scored 0-3. Total range = 0-24 with a higher score indicating better walking ability.
1 time point: 0-10 years post injury
Clinical measure of balance: Retrospective Study
Time Frame: 1 time point: 0-10 years post injury
Clinical measures of balance sharpened Romberg (tandem stance). The length of time a person is able to stand in the eyes open, tandem stance position is recorded up to a maximum of 30 seconds.
1 time point: 0-10 years post injury
Posturography: Retrospective Study
Time Frame: 1 time point: 0-10 years post injury
Postural sway quotient. Postural sway (mm/s) is measured via force plates. The ratio of the sway with eyes open and eyes closed is calculated (unitless ratio).
1 time point: 0-10 years post injury
Perception of verticality: Retrospective Study
Time Frame: 1 time point: 0-10 years post injury
Rod and Disk test: The ability to orientate a line to vertical is assessed with / without visual distractors. The error from vertical is recorded in degrees. Outcomes range from 0-180 degrees where lower numbers indicate better verical perception.
1 time point: 0-10 years post injury
Functional MRI response to an optokinetic stimulus: Retrospective Study
Time Frame: 1 time point: 0-10 years post injury
Regions of interest will also assess changes in activation with an optokinetic stimulus compared to rest in cortical and subcortical sites that process vestibular information namely the insulo-parietal cortex and hippocampus and sites that process other sensory information namely the visual cortex and somatosensory cortex
1 time point: 0-10 years post injury
Vestibular Evoked myogenic Potentials latency: Retrospective Study
Time Frame: 1 time point: 0-10 years post injury
Galvanic and Auditory Vestibular Evoked myogenic Potentials (VEMPs) will be assessed and the latency of evoked responses measured in milliseconds.
1 time point: 0-10 years post injury
Vestibular Evoked myogenic Potentials amplitude: Retrorospective Study
Time Frame: 1 time point: 0-10 years post injury
Galvanic and Auditory Vestibular Evoked myogenic Potentials (VEMPs) will be assessed and the amplitude of evoked responses measured in millivolts.
1 time point: 0-10 years post injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

September 1, 2028

Study Registration Dates

First Submitted

April 8, 2024

First Submitted That Met QC Criteria

April 12, 2024

First Posted (Actual)

April 17, 2024

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 12, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 337421

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Following study completion and publication of results anonymous data sets of clinical and laboratory outcome measures will be made available to other research teams on written request.

IPD Sharing Time Frame

Data will become available on study completion and after publication of results.

IPD Sharing Access Criteria

Access to data will be via written request from other relevant healthcare professionals and research groups.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Decompression Sickness

3
Subscribe